Natpara (parathyroid Hormone recalls
The FDA has published 4 recalls involving Natpara (parathyroid Hormone since 2019. The latest was reported on 2 Oct 2019. Most were for particulate matter. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls4since 2019
Last 12 months0reported
Class I4100% of total
Ongoing0latest 2 Oct 2019
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 4 100%Class II 0 0%Class III 0 0%
Why natpara (parathyroid hormone is recalled
Companies
By year
All natpara (parathyroid hormone recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Natpara (parathyroid hormone) for Injection recalled | Shire Human Genetic Therapies | Particulate Matter | Nationwide |
| Drug | CLASS I | Natpara (parathyroid hormone) for Injection recalled | Shire Human Genetic Therapies | Particulate Matter | Nationwide |
| Drug | CLASS I | Natpara (parathyroid hormone) for Injection recalled | Shire Human Genetic Therapies | Particulate Matter | Nationwide |
| Drug | CLASS I | Natpara (parathyroid hormone) for Injection, 25 mcg/dose cartridges recalled | Shire Human Genetic Therapies | Particulate Matter | Nationwide |
Should you stop taking Natpara (parathyroid Hormone?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.